BBAGF (BB Biotech AG) Ending Cash Position: $451 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBAGF BB Biotech AG BBAGF
15 GF Score
Price $76.06
! 4 Warning Signs
View Full Analysis

What is BB Biotech AG Ending Cash Position?

BB Biotech AG BBAGF -29.53% 15 Ending Cash Position is $451 Mil as of Mar. 2026. GuruFocus rates BBAGF with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

BB Biotech AG's Ending Cash Position for the quarter that ended in Mar. 2026 was $451 Mil.

BB Biotech AG's quarterly Ending Cash Position increased from Sep. 2025 ($103 Mil) to Dec. 2025 ($123 Mil) and increased from Dec. 2025 ($123 Mil) to Mar. 2026 ($451 Mil).

BB Biotech AG's annual Ending Cash Position declined from Dec. 2023 ($1 Mil) to Dec. 2024 ($1 Mil) but then increased from Dec. 2024 ($1 Mil) to Dec. 2025 ($123 Mil).

BB Biotech AG Ending Cash Position Related Terms

BB Biotech AG Ending Cash Position Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG Ending Cash Position Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.08 2.09 0.58 0.51 123.25

BB Biotech AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.42 2.65 102.92 123.25 450.87
BBAGF
15GF Score
BB Biotech AG BBAGF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

BB Biotech AG's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.57499999999997+122.673
=123

BB Biotech AG's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=124.751+326.12
=451

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $451 Mil mean?
BB Biotech AG (BBAGF) has a Ending Cash Position of $451 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on BB Biotech AG and its competitors.
Is BB Biotech AG's Ending Cash Position too high?
BB Biotech AG's current Ending Cash Position is $451 Mil. Overall, BB Biotech AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Ending Cash Position compare to VRTX and REGN?
BB Biotech AG's Ending Cash Position of $451 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current Ending Cash Position is $451 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (BBAGF) has a current Ending Cash Position of $451 Mil. The current Ending Cash Position is $451 Mil. BB Biotech AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For BB Biotech AG (BBAGF), the current Ending Cash Position is $451 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Other Exchanges BION:Switzerland
Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
15GF Score

Get the complete analysis for BBAGF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$76.06
Price